Emodin induces liver injury by inhibiting the key enzymes of FADH/NADPH transport in rat liver
Emodin induces liver injury by inhibiting the key enzymes of FADH/NADPH transport in rat liver
复制标题
大黄素通过抑制大鼠肝脏FADH/NADPH转运关键酶诱导肝损伤
DOI:
10.1039/c7tx00307b
复制
发表时间:
2018
影响因子:
2.1
通讯作者:
Hongbin Xiao
中科院分区:
文献类型:
--
作者:
Xiaowei Yang;Yinhuan Zhang;Yan Liu;Chang Chen;Wenjuan Xu;Hongbin Xiao
Emodin is a natural anthraquinone derivative that occurs in many Chinese medicinal herbs. It might induce liver damage, but the mechanism is not clear. In this research, seven groups of Sprague-Dawley (SD) rats with three doses of emodin were used. The liver injury was examined by analyzing biochemical indexes and histopathology. Altered proteins between the control group (CG) and the liver injury group were determined by proteomic technology. The results showed that emodin causes liver injury in a time- and dose-dependent manner. In the high-dosage 1-week group (HG1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was downregulated, and the activity of malate dehydrogenase (MDH) was inhibited by emodin. These might cause the inhibition of FADH or NADH/NADPH transport from the cytoplasm to mitochondria. The WB results showed that the inhibition of FADH/NADPH transport induced a high activity of caspase-9 and caspase-3, and the expressions of cytochrome c (Cyt C), caspase-9 and caspase-3 were high in HG1, which might lead to mitochondrial apoptosis pathway activation. In addition, whatever the HG1 or low-dose group (LG), the effects of emodin on mitochondria were observed. Overall, for the first time, we showed that emodin inhibited proton transport and induced the activation of the mitochondrial apoptosis pathway, which might be the reason for liver injury.